Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chihiro Yokoo is active.

Publication


Featured researches published by Chihiro Yokoo.


FEBS Letters | 1991

Novel epoxysuccinyl peptides Selective inhibitors of cathepsin B, in vitro

Mitsuo Murata; Satsuki Miyashita; Chihiro Yokoo; Musaharu Tamai; Kazunori Hanada; Katsuo Hatayama; Takae Towatari; Takeshi Nikawa; Nobuhiko Katunuma

A series of new epoxysuccinyl peptides were designed and synthesized to develop a specific inhibitor of cathepsin B. Of these compounds, N‐(L‐3‐trans‐ethoxycarbonyloxirane‐2‐carbonyl)‐L‐isoleucyl‐L‐proline (compound CA‐030) and N‐(L‐3‐trans‐propylcarbamoyloxirane‐2‐carbonyl)‐L‐isoleucyl‐L‐proline (compound CA‐074) were the most potent and specific inhibitors of cathepsin B in vitro. The carboxyl group of proline and the ethyl ester group or n‐propylamide group in the oxirane ring were necessary, the ethyl ester group or the n‐propylamide group being particularly effective for distinguishing cathepsin B from other cysteine proteinases such as cathepsins L and H, and calpains.


FEBS Letters | 1991

Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivo

Takae Towatari; Takeshi Nikawa; Mitsuo Murata; Chihiro Yokoo; Masaharu Tamai; Kazunori Hanada; Nobuhiko Katunuma

New derivatives of E‐64 (compound CA‐030 and CA‐074) were tested in vitro and in vivo for selective inhibition of cathepsin B. They exhibited 10000–30000 times greater inhibitory effects on purified rat cathepsin B than on cathepsin H and L; their initial K 1 values for cathepsin B were about 2–5 nM, like that of E‐64‐c, whereas their initial K 1 values for cathepsins H and L were about 40–200 μM. In in vivo conditions, such us intraperitoneal injection of compound CA‐030 or CA‐074 into rats, compound CA‐074 is an especially potent selective inhibitor of cathepsin B, whereas compound CA‐030 does not show selectivity for cathepsin B, although both compounds CA‐030 and CA‐074 show complete selectivity for cathepsin B in vitro.


Cellular and Molecular Life Sciences | 1994

Aragusterol C : a novel halogenated marine steroid from an Okinawan sponge, Xestospongia sp., possessing potent antitumor activity

H. Shimura; K. Iguchi; Y. Yamada; Shiro Nakaike; Takehiro Yamagishi; Keita Matsumoto; Chihiro Yokoo

A novel chlorinated steroid, aragusterol C, was isolated from an Okinawan marine sponge of the genusXestospongia. The compound strongly inhibited the proliferation of KB cells in vitro, and also showed potent in vivo antitumor activity against L1210 cells in mice. The complete structure of aragusterol C was determined by spectroscopic analysis and X-ray crystallographic analysis.


Journal of The Chemical Society-perkin Transactions 1 | 1993

Synthesis and configurational assignment of methyl 3-nitrooxypropyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate

Toshihisa Ogawa; Keita Matsumoto; Chihiro Yokoo; Katsuo Hatayama; Kunihiro Kitamura

Enantiomeric (+)- and (–)-methy3-nitrooxypropyl 1,4-dihydro-2,6-dimethyl-4-(3- nitrophenyl) pyridine-3,5-dicarboxylate 1 were synthesized by esterification of the optically active monocarboxylic acids (+)-6 and (–)-6, which are available from racemate (±)-6 by optical resolution using cinchonidine and cinchonine. The absolute configuration of the key intermediates (S)-(+)-6 and (R)-(–)-6, was also unambiguously determined by the comparison with optical active (+)- and (–)-1 derived from (R)-(–)- and (S)-(+)-7 and (+)- and (–)-6, and X-ray crystallographic analysis of bromoethyl ester (R)-(–)-8 prepared from the acid (S)-(+)-7.


The Journal of Antibiotics | 1992

Studies on cephalosporin antibiotics. VI. Synthesis, antibacterial activity and oral efficacy in mice of new 7.BETA.-((Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)-acetamido)-3-(substituted alkylthio)cephalosporins.

Chihiro Yokoo; Akira Onodera; Hiroshi Fukushima; Kazuo Numata; Takatoshi Nagate

A series of new 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido] cephalosporins (1) having various substituted alkylthio groups at the C-3 position of the cephem nucleus were prepared and evaluated for antibacterial activity and oral absorption in rats. Of these, the cephalosporin with a cyanomethylthio group (1a) showed the greatest activity against Staphylococcus aureus and Gram-negative bacteria. Its pivaloyloxymethyl ester (6a), a representative prodrug, exhibited good in vivo efficacy in mice by oral administration. The structure-activity relationships of 1 are also presented.


Chemical & Pharmaceutical Bulletin | 1987

Efficient synthetic method for ethyl (+)-(2S,3S)-3-((S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl)-2-oxiranecarboxylate (EST), a new inhibitor of cysteine proteinases.

Masaharu Tamai; Chihiro Yokoo; Mitsuo Murata; Kiyoshi Oguma; Kaoru Sota; Eisuke Sato; Yuichi Kanaoka


Journal of Organic Chemistry | 1994

ARAGUSTEROL B AND D, NEW 26,27-CYCLOSTEROLS FROM THE OKINAWAN MARINE SPONGE OF THE GENUS XESTOSPONGIA

Kazuo Iguchi; Hiromi Shimura; Shouta Taira; Chihiro Yokoo; Keita Matsumoto; Yasuji Yamada


Archive | 1996

Epoxysuccinic acid derivatives

Mitsuo Murata; Chihiro Yokoo; Kazunori Hanada


Archive | 2004

Method for production of cis-4-fluoro-L-proline derivatives

Kazuyuki Tomisawa; Dai Tatsuta; Tomomichi Yoshida; Chihiro Yokoo


Archive | 2004

Process for production of cis-4-fluoro-l-proline derivatives

Kazuyuki Tomisawa; Dai Tatsuta; Tomomichi Yoshida; Chihiro Yokoo

Collaboration


Dive into the Chihiro Yokoo's collaboration.

Top Co-Authors

Avatar

Akira Onodera

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Mitsuo Murata

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kaoru Sota

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Katsuo Hatayama

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Jiro Sawada

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kazunori Hanada

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Masami Goi

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Toshifumi Asaka

Taisho Pharmaceutical Co.

View shared research outputs
Researchain Logo
Decentralizing Knowledge